CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 21 enrolled
Drug / intervention
Telemedicineother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02428803
NCT02428803N/ACompleted

Interactive Videoconferencing in the Provision of Remote Peritoneal Dialysis

University of Alabama at Birmingham·observational·Posted Apr 29, 2015·Updated Oct 1, 2021

In Brief

An observational study evaluating Telemedicine for ESRD. Completed, enrolled 21 participants across 1 site.

Detailed Summary

Home dialysis patients must be seen in a face to face visit on a monthly basis. For patients who live remotely these visits may impact their quality of life due to the amount of time needed to attend these visits. The central hypothesis is that implementation of telemedicine visits as a substitute for the 2 out of 3 monthly face-to-face visits over a 6 month period will improve quality of life as judged by the quality of life (QoL) indices Kidney Disease Quality of Life - Short Form and the Illness Intrusiveness Ratings Scale when compared to QoL scales taken during a time period when the patient is on standard of care.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsESRD
CountriesUnited States

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedApr 29, 2015
Enrollment StartApr 1, 2015
Primary CompletionNov 17, 2020
TodayJul 2, 2026
Enrollment to primary: 5.6 yearsPosted 11.2 years ago

Interventions

Telemedicineother

Patients will be administered the KDQOL-SF and the IIRS and will all start in the standard of care arm. During this time period the patients will receive 6 months of visits as per the usual standard of care. At the end of 6 months the KDQOL-SF and IIRS will again be administered. The patient will then transition to the telemedicine arm of the study for the duration of 6 months. During this time, the patient will come to the dialysis unit on a quarterly basis for a standard visit with labs being drawn in-center and for an in-center Kt/V. For the 2 months following the visit ,however, the patient will not be required to come to the dialysis unit. The monthly face to face and labs will be achieved remotely